Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
CC transcript
Appointed director
Quarterly results
|
|
ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/08/2018 |
BW
| Arrowhead Pharmaceuticals Reports Fiscal 2018 Second Quarter Results |
| 04/24/2018 |
BW
| Arrowhead Pharmaceuticals to Webcast Fiscal 2018 Second Quarter Results |
| 03/06/2018 |
BW
| Arrowhead to Present at Barclays Global Healthcare Conference 2018 |
| 02/09/2018 |
BW
| Arrowhead Pharmaceuticals Reports Fiscal 2018 First Quarter Results |
| 02/02/2018 |
BW
| Arrowhead Pharmaceuticals to Webcast Fiscal 2018 First Quarter Results |
| 12/12/2017 |
BW
| Arrowhead Pharmaceuticals Reports Fiscal 2017 Year End Results |
| 12/05/2017 |
BW
| Arrowhead Pharmaceuticals to Webcast 2017 Fiscal Year End Results |
| 11/14/2017 |
BW
| Arrowhead to Present at 29th Annual Piper Jaffray Healthcare Conference |
| 09/14/2017 |
BW
| Arrowhead Hosts Investor & Analyst R&D Day to Introduce TRiM™ Platform and Lead RNAi-based Drug Candidates |
| 09/01/2017 |
BW
| Arrowhead Pharmaceuticals to Host R&D Day on RNAi-Based Therapies |
| 08/03/2017 |
BW
| Arrowhead Reports Fiscal 2017 Third Quarter Results |
| 07/27/2017 |
BW
| Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Third Quarter Results |
| 05/03/2017 |
BW
| Arrowhead Reports Fiscal 2017 Second Quarter Results |
| 04/26/2017 |
BW
| Arrowhead Pharmaceuticals to Webcast Fiscal 2017 Second Quarter Results |
| 02/06/2017 |
BW
| Arrowhead Reports Fiscal 2017 First Quarter Results |
| 01/30/2017 |
BW
| Arrowhead Pharmaceuticals to Webcast Fiscal 2017 First Quarter Results |
| 06/09/2011 |
BW
| Arrowhead Receives Additional 180 Day Grace Period to Comply with the NASDAQ $1.00 Minimum Bid Requirement |
| 05/12/2011 |
BW
| Arrowhead Reports Fiscal 2011 Second Quarter Financial Results |
| 05/04/2011 |
BW
| Arrowhead Research to Report Fiscal 2011 Second Quarter Financial Results and Host Conference Call on Thursday, May 12, 2011 |
| 05/03/2011 |
BW
| Arrowhead Research to Present at the 2011 MDB Capital Group Bright Lights Conference on May 10 |
| 04/27/2011 |
BW
| Arrowhead Research Announces RNAi Leader John J. Rossi, Ph.D. to Join Calando Scientific Advisory Board |
| 04/06/2011 |
BW
| Arrowhead Research Increases Ownership in Ablaris to 64% |
| 03/08/2011 |
BW
| Arrowhead Research to Present at the Roth Capital Partners 23rd Annual OC Growth Stock Conference on March 16 |
| 02/10/2011 |
BW
| Arrowhead Reports Fiscal 2011 First Quarter Financial Results |
| 12/09/2010 |
BW
| Arrowhead CEO Provides Perspective on $4.5 million Alliance Between Subsidiary Unidym and Samsung Electronics |
| 12/08/2010 |
BW
| Unidym Announces Alliance with Samsung Electronics |
| 11/29/2010 |
BW
| BBC Broadcasts Interview with Dr. Samuel Stupp, Founder of Arrowhead Portfolio Company, Nanotope, Inc. |
| 11/23/2010 |
BW
| Arrowhead Strengthens Board of Directors with the Appointment of Dr. Douglass Given |
| 11/04/2010 |
BW
| Arrowhead Portfolio Companies, Calando Pharmaceuticals, Inc. and Nanotope, Inc., Awarded Federal Grants to Advance Therapeutics |
| 10/26/2010 |
BW
| Arrowhead to Present at Oppenheimer 21st Annual Healthcare Conference |
| 10/18/2010 |
BW
| Arrowhead Portfolio Company, Nanotope, Inc. Enters Agreement with Smith & Nephew for the License and Development of Cartilage Regeneration Technology |
| 09/29/2010 |
BW
| Arrowhead CEO Provides Update on Company Strategy and Milestone Achievements |
| 09/28/2010 |
BW
| Arrowhead to Present at 9th Annual Bio Investor Forum |
| 09/23/2010 |
BW
| Arrowhead Increases Ownership in RNAi Subsidiary Calando Pharmaceuticals, Inc. |
|
|
|